Frazier Financial Advisors’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $8.8K | Hold |
70
| – | – | 0.01% | 367 |
|
|
2025
Q1 | $7.74K | Hold |
70
| – | – | 0.01% | 370 |
|
|
2024
Q4 | $9.6K | Hold |
70
| – | – | 0.01% | 347 |
|
|
2024
Q3 | $8.07K | Hold |
70
| – | – | 0.01% | 416 |
|
|
2024
Q2 | $9.64K | Hold |
70
| – | – | 0.01% | 447 |
|
|
2024
Q1 | $9.66K | Hold |
70
| – | – | 0.01% | 419 |
|
|
2023
Q4 | $9.22K | Buy |
+70
| New | +$9.22K | 0.01% | 361 |
|